A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM).

Name: A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM).
Author: Ades, Lionel

A phase II study of the efficacy and safety of an intensified schedule of azacytidine in intermediate-2 and high-risk patients with myelodysplastic syndromes: a study by the Groupe Francophone des Myelodysplasies (GFM). — المؤلف: Ades, Lionel — Haematologica 20200506

المؤلف: Ades, Lionel
النشر: Haematologica 20200506
الوصف: e131-e133 p.
الموضوعات: Adolescent؛ Adult؛ Aged؛ Azacitidine؛ Female؛ Humans؛ Male؛ Middle Aged